Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations

Abstract

Mitochondrial DNA (mtDNA) instability has been observed in different types of cancer, including colorectal, breast, and gastric cancer. The relationship between the occurrence of such alteration and the nuclear microsatellite instability (nMI) status of the neoplastic cells remains controversial. In an attempt to clarify this issue, we sequenced the first and second mtDNA hypervariable regions, and typed the mitochondrial (CA)n dinucleotide polymorphism in 69 patients with primary tumors of the central nervous system (CNS), previously screened for nMI. Tumor samples showed 27 D-loop sequence changes (39.1%) compared to the corresponding blood samples. Microsatellite homoplasmic allele mutations were detected in four cases (5.8%). We did not find significant associations of the mtDNA instability status with clinicopathological parameters including sex, age, tumor size, and duration of clinical course. Neither did we find any association between mtDNA and nuclear instabilities, indicating that, at least in CNS tumors, they respond to different DNA repair mechanisms. We have also compiled the mtDNA instabilities previously reported by other authors for several types of tumors, comparing them to mtDNA polymorphisms in human populations. Most of the tumor-associated changes are common human polymorphisms and mutational hotspots. To explain the molecular behavior of mtDNA instability in tumors, we propose a model also common to other biological situations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and de la Chapelle A . (1993). Science, 260, 812–816.

  • Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM and Howell N . (1999). Nat. Genet., 23, 147.

  • Bandelt H-J, Forster P and Röhl A . (1999). Mol. Biol. Evol., 16, 37–48.

  • Bandelt H-J, Forster P, Sykes BC and Richards MB . (1995). Genetics, 141, 743–753.

  • Bandelt H-J, Quintana-Murci L, Salas A and Macaulay V . (2002). Am. J. Hum. Genet., 71, 1150–1160.

  • Bodenteich A, Mitchell LG, Polymeropoulos MH and Merril CR . (1992). Hum. Mol. Genet., 1, 140.

  • Chinnery PF, Samuels DC, Elson J and Turnbull D . (2002). Lancet, 360, 1323–1325.

  • Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P and Thilly WG . (2001). Nat. Genet., 28, 147–150.

  • Daumas-Duport C, Scheithauer BW, O'Fallon J and Kelly P . (1988). Cancer, 62, 2152–2165.

  • Field JK, Kiaris H, Howard P, Vaughan ED, Spandidos DA and Jones AS . (1995). Br. J. Cancer, 71, 1065–1069.

  • Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J and Sidransky D . (2000). Science, 287, 2017–2019.

  • Forster L, Forster P, Lutz-Bonengel S, Willkomm H and Brinkmann B . (2002). Proc. Natl. Acad. Sci. USA, 99, 13950–13954.

  • Gall K, Pavelic J, Jadro-Santel D, Poljak M and Pavelik K . (1993). Int. J. Exp. Pathol., 74, 333–337.

  • Habano W, Nakamura S and Sugai T . (1998). Oncogene, 17, 1931–1937.

  • Habano W, Sugai T, Nakamura SI, Uesugi N, Yoshida T and Sasou S . (2000). Gastroenterology, 118, 835–841, (reply to Schwartz and Perucho. (2000). Gastroenterology, 119, 1806–1807).

  • Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE and Howell N . (2002). Am. J. Hum. Genet., 70, 1152–1171.

  • Ingman M, Kaessmann H, Pääbo S and Gyllensten U . (2000). Nature, 408, 708–713.

  • Ionov I, Peinado MA, Malkhosyan S, Shibata D and Perucho M . (1993). Nature, 363, 558–561.

  • Khrapko K, Coller HA, Andre PC, Li XC, Hanekamp JS and Thilly WG . (1997). Proc. Natl. Acad. Sci. USA, 94, 13798–13803.

  • Kiaris H, Spandidos DA, Jones AS, Vaughan ED and Field JK . (1995). Br. J. Cancer, 1, 123–128.

  • Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H and Dietzmann K . (1999). Genes Chromosomes Cancer, 26, 80–83.

  • Maca-Meyer N, González AM, Larruga JM, Flores C and Cabrera VM . (2001). BMC Genet., 2, 13.

  • Malyarchuk BA, Rogozin IB, Berikov VB and Derenko MV . (2002). Hum. Genet., 111, 46–53.

  • Máximo V, Soares P, Machado JC, Seruca R and Sobrinho-Simoes M . (2000). Gastroenterology, 119, 1808–1809.

  • Meyer S, Weiss G and von Haeseler A . (1999). Genetics, 152, 1103–1110.

  • Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW and Vogelstein B . (1998). Nat. Genet., 20, 291–293.

  • Richards M and Macaulay V . (2001). Am. J. Hum. Genet., 68, 1315–1320.

  • Richards M, Macaulay V, Hickey E, Vega E, Sykes B, Guida V, Rengo C, Sellitto D, Cruciani F, Kivisild T, Villems R, Thomas M, Rychkov S, Rychkov O, Rychkov Y, Golge M, Dimitrov D, Hill E, Bradley D, Romano V, Cali F, Vona G, Demaine A, Papiha S, Triantaphyllidis C, Stefanescu G, Hatina J, Belledi M, Di Rienzo A, Novelletto A, Oppenheim A, Norby S, Al-Zaheri N, Santachiara–Benerecetti S, Scozari R, Torroni A and Bandelt HJ . (2000). Am. J. Hum. Genet., 67, 1251–1276.

  • Risinger JI, Berchuk A, Koheler MF, Watson P, Lynch HT and Boyd J . (1993). Cancer Res., 53, 5100–5103.

  • Salas A, Lareu MV and Carracedo A . (2001). Int. J. Legal Med., 114, 186–190.

  • Salas A, Richards M, De la Fé T, Lareu MV, Sobrino B, Sánchez-Diz P, Macaulay V and Carracedo A . (2002). Am. J. Hum. Genet., 71, 1082–1111.

  • Sobrido MJ, Rodriguez-Pereira C, Barros F, Forteza J, Carracedo A and Lema M . (2000). J. Neurol. Neurosurg. Psychiatry, 69, 369–375.

  • Stoneking M . (2000). Am. J. Hum. Genet., 67, 1029–1032.

  • Thibodeau SN, Bren G and Schaid D . (1993). Science, 260, 816–819.

  • Tully G, Barritt SM, Bender K, Brignon E, Capelli C, Dimo-Simonin N, Eichmann C, Ernst CM, Lambert C, Lareu MV, Ludes B, Mevag B, Parson W, Pfeiffer H, Salas A, Schneider PM and Staalstrom E . (2003). Forensic Sci. Int., submitted.

  • Vega A, Sobrido MJ, Ruiz-Ponte C, Barros F and Carracedo A . (2001). Cancer, 92, 2920–2926.

  • Yee CJ, Roodi N, Verrier CS and Parl FF . (1994). Cancer Res., 54, 1641–1644.

Download references

Acknowledgements

We are grateful to Patrick Chinnery for helpful comments on an advanced version of this manuscript. We express our appreciation to the sample donors. AS has a research contract with the University of Santiago de Compostela. VM was supported by the Wellcome Trust. This work was supported by grants from the Ministerio de Educación y Ciencia (DGCYT-P4. BIO2000-0145-P4-02), Ministerio de Sanidad (FIS 01/0024), and the Xunta de Galicia (PGIDT-01-PXI-20806-PR and PGIDIT02PXIC20804PN), and Ministerio de Sanidad y Consumo (Fondo de Investigación Sanitaria; Instituto de Salud Carlos III, PI030893; SCO/3425/2002).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Salas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vega, A., Salas, A., Gamborino, E. et al. mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 23, 1314–1320 (2004). https://doi.org/10.1038/sj.onc.1207214

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207214

Keywords

This article is cited by

Search

Quick links